<p>INS-1 cells maintained at 2.8 mM glucose for 12 hours were cultured without serum for 6 hours at 2.8 mM glucose before pretreatment for 30 min with DMSO (−) or 10 or 20 µM JNK inhibitor SP600125 (JNKi). Cells were then cultured for 3 or 24 hours at 2.8 or 16.7 mM glucose in the presence of DMSO or JNKi at 10 or 20 µM as indicated. (<b>A</b>) The relative mRNA abundance of <i>Adar2</i> was determined by quantitative RT-PCR. Data represent the mean±SEM from three independent experiments. *P<0.05, **P<0.01. (<b>B</b>) Lysates from cells treated for 24 hours were analyzed by immunoblotting using the indicated antibodies. Results are representative of three independent experiments. (<b>C</b>) The efficiency of ADAR2 auto-editing was analyzed ...
<p>U937 cells were pretreated with 10 µM of JNK inhibitor, SP600125 (SP), for 1 h, followed by the a...
<p>(A) D1 cells continuously cultured with or without IL-7 for 18 hours, or withdrawn (18 hours) and...
<p>INS1 cells stably expressing shRNA directed against JNK1, JNK2, JNK3 or the non-sense control wer...
<p>(<b>A–B</b>) INS-1 β-cells were maintained at 2.8 mM glucose (Glc) for 18 hours and were subseque...
<p>(<b>A</b>) High glucose did not affect the stability of <i>Adar2</i> mRNA transcripts. INS-1 cell...
A-to-I RNA editing catalyzed by the two main members of the adenosine deaminase acting on RNA (ADAR)...
<div><p>A-to-I RNA editing catalyzed by the two main members of the adenosine deaminase acting on RN...
<p>(<b>A</b>) Schematic of pGL3-luciferase (Luc) reporter constructs containing the indicated region...
<p>Cells were transfected with <i>Jnks</i> (si1, si2, si3) or GFP (siGFP) siRNAs for 2 days. Transfe...
<p>Human adipocytes were incubated with 1 nM BPA for 24h and exposed to 20 µM SP600125 for 1 h. a) C...
<p><i>A</i>, γ2A<sup>LEPRb/JAK2</sup> cells were deprived of serum in the presence of 5 or 25 mM glu...
<p>Human adipocytes were incubated in serum free-media with 1 nM BPA, 20 µM SP600125 with or without...
<p>INS1 cells stably expressing shRNA directed against JNK1, JNK2, JNK3 or the non-sense (ns) contro...
<p>(<b>A–B</b>) Primary islets were isolated from male (<b>A</b>) JNK1<sup>−/−</sup> (n = 5) or (<b>...
<p>MC38 cells were cultured with insulin and IGF-1 alone or both together for 72 hours. ERK1/2 inhib...
<p>U937 cells were pretreated with 10 µM of JNK inhibitor, SP600125 (SP), for 1 h, followed by the a...
<p>(A) D1 cells continuously cultured with or without IL-7 for 18 hours, or withdrawn (18 hours) and...
<p>INS1 cells stably expressing shRNA directed against JNK1, JNK2, JNK3 or the non-sense control wer...
<p>(<b>A–B</b>) INS-1 β-cells were maintained at 2.8 mM glucose (Glc) for 18 hours and were subseque...
<p>(<b>A</b>) High glucose did not affect the stability of <i>Adar2</i> mRNA transcripts. INS-1 cell...
A-to-I RNA editing catalyzed by the two main members of the adenosine deaminase acting on RNA (ADAR)...
<div><p>A-to-I RNA editing catalyzed by the two main members of the adenosine deaminase acting on RN...
<p>(<b>A</b>) Schematic of pGL3-luciferase (Luc) reporter constructs containing the indicated region...
<p>Cells were transfected with <i>Jnks</i> (si1, si2, si3) or GFP (siGFP) siRNAs for 2 days. Transfe...
<p>Human adipocytes were incubated with 1 nM BPA for 24h and exposed to 20 µM SP600125 for 1 h. a) C...
<p><i>A</i>, γ2A<sup>LEPRb/JAK2</sup> cells were deprived of serum in the presence of 5 or 25 mM glu...
<p>Human adipocytes were incubated in serum free-media with 1 nM BPA, 20 µM SP600125 with or without...
<p>INS1 cells stably expressing shRNA directed against JNK1, JNK2, JNK3 or the non-sense (ns) contro...
<p>(<b>A–B</b>) Primary islets were isolated from male (<b>A</b>) JNK1<sup>−/−</sup> (n = 5) or (<b>...
<p>MC38 cells were cultured with insulin and IGF-1 alone or both together for 72 hours. ERK1/2 inhib...
<p>U937 cells were pretreated with 10 µM of JNK inhibitor, SP600125 (SP), for 1 h, followed by the a...
<p>(A) D1 cells continuously cultured with or without IL-7 for 18 hours, or withdrawn (18 hours) and...
<p>INS1 cells stably expressing shRNA directed against JNK1, JNK2, JNK3 or the non-sense control wer...